ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

Forgot password
  • Home
  • About
  • News
  • Tybost (Cobicistat) and Vitekta (Elvitegravir) Approved as Individual HIV Drugs

Tybost (Cobicistat) and Vitekta (Elvitegravir) Approved as Individual HIV Drugs

28 Sep 2014 7:47 AM | Christopher McCoy

After initially issuing a complete response and denial of the individual drugs in 2013 to Gilead, the FDA approved the drugs last week.  


Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888 • sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software